- Home
- FORR vs BWAY Comparison
FORR vs BWAY Comparison
Compare FORR & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORR
- BWAY
- Stock Information
- Founded
- FORR 1983
- BWAY 2003
- Country
- FORR United States
- BWAY Israel
- Employees
- FORR N/A
- BWAY N/A
- Industry
- FORR Diversified Commercial Services
- BWAY Medical/Dental Instruments
- Sector
- FORR Consumer Discretionary
- BWAY Health Care
- Exchange
- FORR Nasdaq
- BWAY Nasdaq
- Market Cap
- FORR 193.5M
- BWAY 201.1M
- IPO Year
- FORR 1996
- BWAY 2019
- Fundamental
- Price
- FORR $9.57
- BWAY $10.96
- Analyst Decision
- FORR
- BWAY Strong Buy
- Analyst Count
- FORR 0
- BWAY 2
- Target Price
- FORR N/A
- BWAY $14.25
- AVG Volume (30 Days)
- FORR 63.5K
- BWAY 33.0K
- Earning Date
- FORR 07-29-2025
- BWAY 08-05-2025
- Dividend Yield
- FORR N/A
- BWAY N/A
- EPS Growth
- FORR N/A
- BWAY N/A
- EPS
- FORR N/A
- BWAY 0.08
- Revenue
- FORR $422,269,000.00
- BWAY $43,457,000.00
- Revenue This Year
- FORR N/A
- BWAY $351.53
- Revenue Next Year
- FORR $2.04
- BWAY $21.84
- P/E Ratio
- FORR N/A
- BWAY $54.48
- Revenue Growth
- FORR N/A
- BWAY 26.86
- 52 Week Low
- FORR $8.50
- BWAY $5.67
- 52 Week High
- FORR $20.62
- BWAY $12.00
- Technical
- Relative Strength Index (RSI)
- FORR 42.40
- BWAY 58.38
- Support Level
- FORR $9.59
- BWAY $10.81
- Resistance Level
- FORR $10.11
- BWAY $11.40
- Average True Range (ATR)
- FORR 0.52
- BWAY 0.46
- MACD
- FORR -0.12
- BWAY -0.03
- Stochastic Oscillator
- FORR 15.38
- BWAY 50.88
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.